Connor, Clark & Lunn Investment Management (CC&L)
OXFD

Connor, Clark & Lunn Investment Management (CC&L)’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-32,843
Closed -$574K – 1145
2020
Q4 		$574K Sell
32,843
-7,215
-18% -$101K ﹤0.01% 708
2020
Q3 		$469K Sell
40,058
-25,104
-39% -$333K ﹤0.01% 736
2020
Q2 		$847K Sell
65,162
-29,063
-31% -$349K 0.01% 651
2020
Q1 		$873K Sell
94,225
-25,275
-21% -$353K 0.01% 588
2019
Q4 		$1.98M Sell
119,500
-1,200
-1% -$19.5K 0.01% 418
2019
Q3 		$2.01M Buy
120,700
+62,225
+106% +$861K 0.01% 411
2019
Q2 		$805K Buy
+58,475
New +$894K 0.01% 617

Connor, Clark & Lunn Investment Management (CC&L)'s OXFD Position: Q1 2021 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 32,843 shares — an estimated $574K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in OXFD in Q2 2019 and held it in 7 quarters. The position peaked at $2.01M in Q3 2019. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 32,843 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $574K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2019 and held it in 7 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s Oxford Immunotec Global PLC Ordinary Shares position peaked at $2.01M in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2021, filed 13 May 2021.